Skip to main content
    O

    OmniAb Inc. (OABI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.05
    +0.16 (+3.27%)

    Market Cap: $713.26M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    OmniAb Inc. (OABI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    OmniAb (OABI) has a market cap of $713.26M and an enterprise value of $705.30M. It kept -108.11% of revenue as net income over the last 12 months. Revenue grew 90.63% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 1.12% below the market cap, as cash exceeds debt.

    Market Cap$713.26M
    Enterprise Value$705.30M
    Latest price (Nov 17, 2026)$5.05

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateOct 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.39% in the quarter ended Sep 30, 2026 and grew 12.37% a year over 2 years.

    Shares Outstanding129.29M
    Shares Change (YoY)+12.70%
    Shares Change (QoQ)+0.39%
    Share Count Growth (2Y CAGR)+12.37%

    Valuation Ratios

    Sales and book value multiples are 16.2x and 2.6x. Its year-end P/S ranged from 5.4x to 18.0x from 2022 to 2025.

    P/S Ratio16.2x
    Forward P/S19.2x
    P/B Ratio2.6x
    P/TBV Ratio12.5x
    P/OCF Ratio267.5x

    Valuation history and multiples

    Price Statistics

    The stock is up 223.72% over 52 weeks and trades 5.87% above its 50-day average.

    Beta (1Y)1.25
    52-Week Change+223.72%
    1-Month Change+7.68%
    3-Month Change+20.53%
    6-Month Change+113.08%
    Total Return (1Y)+223.72%
    Total Return (3Y CAGR)+4.31%
    Return vs SPY (1Y)+202.11%
    Max Drawdown (1Y)-37.04%
    Max Drawdown (3Y)-81.32%
    Sharpe Ratio (1Y)1.61
    Correlation with SPY (1Y)0.24
    50-Day Average$4.77
    200-Day Average$2.89
    52-Week Range$1.35 to $5.45
    RSI (14 Days)53.6
    Average Volume (20 Days)1.53M

    Price chart

    Financial Position

    Current assets cover 4.21x current liabilities, and total debt is 0.06x shareholder equity.

    Current Ratio4.21x
    Quick Ratio4.21x
    Debt / Equity0.06x

    Returns and Efficiency

    Return on invested capital is -17.46% over the last 12 months, against a 5-year average of -23.68%.

    Return on Equity (ROE)-17.45%
    Return on Assets (ROA)-14.94%
    Return on Invested Capital (ROIC)-17.46%
    ROE (5Y Average)-16.00%
    ROA (5Y Average)-13.65%
    ROIC (5Y Average)-23.68%
    Asset Turnover0.13x
    Receivables Turnover6.23x

    Scores

    OABI has an Altman Z-Score of 8.27, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score8.27
    Altman Z ZoneSafe
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $40.21M over the last 12 months.

    Revenue$40.21M
    Revenue Growth (YoY)+90.63%
    Gross Profit$39.27M
    Operating Income-$46.60M
    Pretax Income-$43.88M
    Net Income-$43.47M
    EBITDA-$23.99M
    Reported EPS (TTM)-$0.34

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 85.65% of the $290.92M in total assets.

    Cash and Equivalents$22.88M
    Total Debt$14.93M
    Net Cash$7.96M
    Net Cash Per Share$0.06
    Working Capital$54.13M
    Shareholder Equity$249.16M
    Book Value Per Share$1.93
    Tangible Book Value$52.17M
    Tangible Book Per Share$0.40
    Total Assets$290.92M
    Total Liabilities$41.76M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow$2.67M
    FCF Per Share$0.02
    Depreciation and Amortization$23.05M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -115.89%.

    Gross Margin97.65%
    Operating Margin-115.89%
    Pretax Margin-109.12%
    Net Margin-108.11%
    EBITDA Margin-59.65%
    Gross Margin (5Y Average)99.68%

    Growth

    Revenue fell 31.89% a year over 3 years.

    Revenue Growth (3Y CAGR)-31.89%
    Revenue Growth (5Y CAGR)-4.31%
    Book Value Per Share Growth (2Y CAGR)-18.43%
    Tangible Book Per Share Growth (2Y CAGR)-22.29%

    Revenue and profit by year

    Dividends and Yields

    OABI does not pay a dividend.

    Buyback Yield-0.32%
    Shareholder Yield-0.32%

    Peer Position

    Against 4 similar companies, OABI has the 4th highest P/S.

    P/S Ratio16.2x vs 65.1x median
    ROIC-17.46% vs -46.80% median
    Revenue Growth (Trailing 4 Quarters, YoY)+90.63% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 58.67% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+58.67%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OABI

    What is OABI's market cap?

    OmniAb has a market cap of $713.26M. Its enterprise value, which adds debt and subtracts cash, is $705.30M.

    How many shares of OABI are outstanding?

    OmniAb has 129.29M shares outstanding. The count is up 12.70% from a year earlier.

    Does OABI pay a dividend?

    No. OmniAb does not pay a dividend.

    How much debt does OABI have?

    OmniAb has $14.93M of total debt and $22.88M of cash and equivalents, a net cash position of $7.96M.